Personalized Oncology
Showing 1 - 25 of 4,878
Hereditary Cancer, Genetic Testing Trial (Relational agent (RA) / Chatbot, Enhanced Usual Care (EUC))
Not yet recruiting
- Hereditary Cancer
- Genetic Testing
- Relational agent (RA) / Chatbot
- Enhanced Usual Care (EUC)
- (no location specified)
Oct 10, 2023
Solid Tumor Trial in Copenhagen (Tumor biopsy)
Recruiting
- Unspecified Adult Solid Tumor, Protocol Specific
- Tumor biopsy
-
Copenhagen, DenmarkRigshospitalet
Oct 25, 2022
Personalized Exercise Oncology
Active, not recruiting
- Cancer
- Health Behavior
- Survey
-
Heidelberg, GermanyHeidelberg University Hospital
Feb 18, 2022
Neuroendocrine Tumors Trial in Sweden (177Lu-DOTATOC, Capecitabine)
Not yet recruiting
- Neuroendocrine Tumors
-
Göteborg, Sweden
- +3 more
May 19, 2022
Pancreatic Adenocarcinoma Trial in Lausanne (Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC
Recruiting
- Pancreatic Adenocarcinoma
- Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC vaccine)
-
Lausanne, Vaud, SwitzerlandCHUV Oncology Department
Jun 23, 2022
Oncology Trial in Luxembourg (Personalized Functional Profiling)
Recruiting
- Oncology
- Personalized Functional Profiling
-
Luxembourg, Luxembourg
- +1 more
Feb 23, 2022
NSCLC Trial in Lausanne (Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine), Low dose
Recruiting
- Non-small Cell Lung Cancer
- Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
- Low dose cyclophosphamide
-
Lausanne, Vaud, SwitzerlandCHUV Oncology Department
Jan 17, 2022
NSCLC Stage IIIB, ALK Gene Mutation Trial in Mexico City (Alectinib Oral Product)
Recruiting
- Non-small Cell Lung Cancer Stage IIIB
- ALK Gene Mutation
- Alectinib Oral Product
-
Mexico City, MexicoThoracic Oncology Unit and Personalized Medicine Laboratory, Ins
Jan 26, 2023
Gastric Cancer Trial in Beijing (neoantigen tumor vaccine with or without PD-1/L1)
Not yet recruiting
- Gastric Cancer
- neoantigen tumor vaccine with or without PD-1/L1
-
Beijing, ChinaDepartment of GI Oncology, Peking University Cancer Hospital,
Jan 26, 2022
Pancreatic Cancer Trial in New York (OncoTreat)
Recruiting
- Pancreatic Cancer
- OncoTreat
-
New York, New YorkColumbia University Medical Center
Jun 9, 2021
Overweight and Obesity, Cardiovascular Diseases, Metabolic Syndrome Trial in Bari
Not yet recruiting
- Overweight and Obesity
- +3 more
-
Bari, BA, ItalyDepartment of Biomedical Sciences and Human Oncology - Clinica m
Jul 1, 2022
Extensive Stage Small Cell Lung Cancer Trial in Shanghai (HLX10, carboplatin and etoposide, )
Active, not recruiting
- Extensive Stage Small Cell Lung Cancer
- HLX10
- +2 more
-
Shanghai, China
- +5 more
Sep 28, 2022
Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)
Recruiting
- Non-Small Cell Lung Cancer
- +4 more
- GRT-C903
- +3 more
-
Phoenix, Arizona
- +13 more
Jan 30, 2023
Melanoma Trial in Australia, United States (mRNA-4157, Pembrolizumab)
Active, not recruiting
- Melanoma
- mRNA-4157
- Pembrolizumab
-
Tucson, Arizona
- +21 more
Aug 23, 2022
Biliary Tract Tumors Trial in Belgium, France, United Kingdom (Futibatinib, Ivosidenib, Zanidatamab)
Not yet recruiting
- Biliary Tract Neoplasms
- Futibatinib
- +9 more
-
Brussels, Belgium
- +56 more
Nov 7, 2022
Melanoma (Skin), Squamous Cell Carcinoma of the Skin, Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (CV8102,
Active, not recruiting
- Melanoma (Skin)
- +3 more
- CV8102
- CV8102 + anti-PD-1 therapy
-
Graz, Austria
- +21 more
Nov 3, 2021
Familial Adenomatous Polyposis Trial in Amsterdam (Personalized surveillance and intervention protocol)
Recruiting
- Familial Adenomatous Polyposis
- Personalized surveillance and intervention protocol
-
Amsterdam, Noord-Holland, NetherlandsAcademic Medical Centre
Dec 16, 2020
Carcinomatosis, Peritoneal, Pancreas Cancer, Ovarian Cancer Trial in Gent, Ghent (MRI)
Recruiting
- Carcinomatosis, Peritoneal
- +3 more
- MRI
-
Gent, Belgium
- +1 more
Aug 10, 2020
TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)
Active, not recruiting
- TNBC - Triple-Negative Breast Cancer
- Breast Cancer
- Trilaciclib
- +3 more
-
Birmingham, Alabama
- +111 more
Oct 25, 2022
Familial Adenomatous Polyposis Trial in Amsterdam (Personalized surveillance and intervention protocol)
Recruiting
- Familial Adenomatous Polyposis
- Personalized surveillance and intervention protocol
-
Amsterdam, Noord-Holland, NetherlandsAcademic Medical Centre
Dec 16, 2020
Refractory Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Moscow (Preparative regimen)
Recruiting
- Refractory Acute Myeloid Leukemia
- Refractory Acute Lymphoblastic Leukemia
- Preparative regimen
-
Moscow, Russian FederationDmitry Rogachev National Research Center of Pediatric Hematology
Nov 19, 2020
Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma Trial in Australia, United States (GRT-C901,
Active, not recruiting
- Non Small Cell Lung Cancer
- +3 more
- GRT-C901
- +3 more
-
Phoenix, Arizona
- +10 more
Aug 31, 2021
Long Term Cancer Side Effects, Supportive Care in Cancer, Cancer Survivorship Care Plan Trial in Caen (Day hospitalization in
Recruiting
- Long Term Cancer Side Effects
- +4 more
- Day hospitalization in support care with meeting with support care professionals and coordination of actions by the advanced practice nurse
- +2 more
-
Caen, FranceCentre Francois Baclesse
Feb 7, 2023
Neuroendocrine Tumors Trial in Warszawa (177Lu-DOTATOC)
Unknown status
- Neuroendocrine Tumors
-
Warszawa, PolandCentrum Diagnostyczno-Lecznicze Gammed
Nov 2, 2020
Circulating Tumor DNA in Pancreatic Cancer UsingPersonalized
Recruiting
- Pancreatic Cancer
- No intervention
-
Kashiwa, JapanNational Cancer Center Hospital East
Sep 12, 2023